Capricorn Fund Managers LTD Bei Gene, Ltd. Transaction History

Capricorn Fund Managers LTD

  • $122 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023
BUY
$179.87 - $225.13 $2.47 Million - $3.09 Million
13,735 New
13,735 $2.47 Million
Q1 2023

Apr 18, 2023
BUY
$215.53 - $274.5 $1.53 Million - $1.95 Million
7,102 New
7,102 $1.53 Million
Q2 2022

Aug 10, 2022
BUY
$121.11 - $216.05 $2.11 Million - $3.76 Million
17,392 Added 722.26%
19,800 $3.21 Million
Q1 2022

May 10, 2022
BUY
$146.52 - $269.56 $352,820 - $649,100
2,408 New
2,408 $454,000

Others Institutions Holding BGNE

# of Institutions
250
Shares Held
45.3M
Call Options Held
292K
Put Options Held
119K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $19.8B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Capricorn Fund Managers LTD Portfolio

Follow Capricorn Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capricorn Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capricorn Fund Managers LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email